Kto vyrába Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Reckitt Benckiser (Healthcare) SA-NV (BE)

Do ktorej ATC triedy patrí Gaviscon Adapted Formulation Mint 250 mg chewable tabl.?

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: ATC A02BX13 Alginic Acid. ATC je klasifikácia WHO pre skupiny liečiv.

OTC

Gaviscon Adapted Formulation Mint 250 mg chewable tabl.: Chewable tablet (Oral use)

Chewable tablet

INN: Sodium Alginate

Aktualizované: 2026-04-11

Dostupné v:

🇩🇪🇬🇧🇷🇴🇷🇺🇹🇷

Forma

Chewable tablet

Dávkovanie

—

Spôsob podania

Oral use

Skladovanie

—

O lieku

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.